An Investigational Immuno-therapy Safety and Effectiveness Study of Nivolumab in Combination With Brentuximab Vedotin to Treat Non-Hodgkin Lymphomas
Clinical trial NCT02581631 · COMPLETED
Trial details
- NCT number
- NCT02581631
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-11
- Primary completion
- 2020-01-16
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.